Evidence map›Paper›PMID 26209157›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2015

Low Systemic Oxygen Delivery and BP and Risk of Progression of Early AKI.

Mario Raimundo, Siobhan Crichton, Yadullah Syed, Jonathan R Martin, Richard Beale, David Treacher, Marlies Ostermann

Registry-linked trialAbstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04895384 (El DORADO STUDY), which is not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04895384 unknown statusnot on this mapstarted 2021, after this paper: background citation

El DORADO STUDY (Evaluation of Delivery of Oxygen on Renal, Arrhythmia and Delirium Outcomes Study)

TypeobservationalSponsorNational University Hospital, SingaporeRan2021 to 2024Enrolled600ConditionsAKI, Neurocognitive Disorders, Atrial FibrillationArmsEdwards ClearSight and Masimo SET
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Is Timing Everything?The journal of extra-corporeal technology · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mario RaimundoDepartment of Critical Care, King's College London, Guy's and St. Thomas' Foundation Hospital, London, United Kingdom; Santa Maria Hospital, North Lisbon Hospital Center, Lisbon, Portugal; and.
Siobhan CrichtonDivision of Health and Social Care Research, King's College London, London, United Kingdom.
Yadullah SyedDepartment of Critical Care, King's College London, Guy's and St. Thomas' Foundation Hospital, London, United Kingdom;
Jonathan R MartinDepartment of Critical Care, King's College London, Guy's and St. Thomas' Foundation Hospital, London, United Kingdom;
Richard BealeDepartment of Critical Care, King's College London, Guy's and St. Thomas' Foundation Hospital, London, United Kingdom;
David TreacherDepartment of Critical Care, King's College London, Guy's and St. Thomas' Foundation Hospital, London, United Kingdom;
Marlies OstermannDepartment of Critical Care, King's College London, Guy's and St. Thomas' Foundation Hospital, London, United Kingdom; marlies.ostermann@gstt.nhs.uk.
King's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe optimal hemodynamic management of patients with early AKI is unknown. This study aimed to investigate the association between hemodynamic parameters in early AKI and progression to severe AKI and hospital mortality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study retrospectively analyzed the data of all patients admitted to the adult intensive care unit in a tertiary care center between July 2007 and June 2009 and identified those with stage 1 AKI (AKI I) per the AKI Network classification. In patients in whom hemodynamic monitoring was performed within 12 hours of AKI I, hemodynamic parameters in the first 12 hours of AKI I and on the day of AKI III (if AKI III developed) or 72 hours after AKI I (if AKI III did not develop) were recorded. Risk factors for AKI III and mortality were identified using univariate and multivariate logistic regression analyses.

resultsAmong 790 patients with AKI I, 210 (median age 70 years; 138 men) had hemodynamic monitoring within 12 hours of AKI I; 85 patients (41.5%) progressed to AKI III and 91 (43%) died in the hospital. AKI progressors had a significantly higher Sequential Organ Failure Assessment score (8.0 versus 9.6; P<0.001), lower indexed systemic oxygen delivery (DO2I) (median 325 versus 405 ml/min per m(2); P<0.001), higher central venous pressure (16 versus 13; P=0.02), and lower mean arterial blood pressure (MAP) (median 71 versus 74 mmHg; P=0.01) in the first 12 hours of AKI I compared with nonprogressors. Multivariate analysis confirmed that raised lactate, central venous pressure, and Sequential Organ Failure Assessment score as well as mechanical ventilation were independently associated with progression to AKI III; higher DO2I and MAP were independently associated with a lower risk of AKI III but not survival. The associations were independent of sepsis, heart disease, recent cardiac surgery, or chronic hypertension.

conclusionsHigher DO2I and MAP in early AKI were independently associated with a lower risk of progression.

Indexed as

Arterial PressureRespiration, ArtificialAcute Kidney InjuryAgedBiomarkersChi-Square DistributionComorbidityDisease ProgressionFemaleHospital MortalityHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisOdds RatioBiomarkersOxygenARFhypotensionkidney failuremortality risk

Identifiers

PMID26209157
PMCPMC4527018
OpenAlexW2105354400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.